Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 11—November 2026
Synopsis
Predictors and Patterns of Metastatic Candidozyma auris Infection, Spain, 2016–2024
Table 3
Landmark analysis of factors associated with metastatic infection in patients with Candidozyma auris candidemia, Spain, 2016–2024*
| Variable | sHR (95% CI) | p value |
|---|---|---|
| Persistent candidemia at day 5 | 2.67 (0.86–8.32) | 0.091 |
| Age, per year | 1.02 (0.98–1.06) | 0.413 |
| Previous candidemia | 1.37 (0.31–6.13) | 0.688 |
| Cardiac device/prosthetic valve | 4.04 (1.19–13.7) | 0.025 |
| Recent surgery | 0.99 (0.32–3.07) | 0.943 |
*Analysis restricted to patients surviving beyond day 5 (n = 97). Death was retained as a competing event. sHR, subdistribution hazard ratio.
1These authors contributed equally to this work and are co–first authors.
Page created: September 05, 2026
Page updated: October 14, 2026
Page reviewed: October 14, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.